CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC
Delisted
CTIC was delisted on the 23rd of June, 2023.
62 hedge funds and large institutions have $141M invested in CTI BioPharma Corp. (DE) Common Stock in 2020 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
62
Holders Change
+24
Holders Change %
+63.16%
% of All Funds
1.1%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
29
Increased
12
Reduced
9
Closed
5
Calls
$748K
Puts
$195K
Net Calls
+$553K
Net Calls Change
+$134K
Top Buyers
1 |
CCM
Consonance Capital Management
New York
|
+$8.09M |
2 |
GTC
Ghost Tree Capital
New York
|
+$2.42M |
3 |
Millennium Management
New York
|
+$1.23M |
4 |
Morgan Stanley
New York
|
+$1.21M |
5 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
+$966K |
Top Sellers
1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$5.52M |
2 |
CC
Caxton Corporation
Princeton,
New Jersey
|
-$1.82M |
3 |
Renaissance Technologies
New York
|
-$1.28M |
4 |
Two Sigma Advisers
New York
|
-$355K |
5 |
![]()
Group One Trading
Chicago,
Illinois
|
-$71K |